Literature DB >> 17515803

Effects of tobacco and cigarette smoke extracts on serotonergic raphe neurons in the rat.

Khalid Touiki1, Pascal Rat, Robert Molimard, Abderrahman Chait, Renaud de Beaurepaire.   

Abstract

Tobacco components other than nicotine might participate in the behavioural effects of smoking. In this study, in-vivo recordings of serotonergic dorsal raphe neurons were performed in the anesthetized rat, whereas tobacco extracts, cigarette smoke extracts, nicotine, nornicotine or anabasine were intravenously injected. All substances inhibited the neurons, and all inhibitions were completely blocked by the nicotine receptor antagonist mecamylamine. The effects of the extracts were much more potent than those of individual substances. These results support the hypothesis that the acute inhibition of serotonin neurons by tobacco compounds is completely related to an effect on nicotine receptors. Tobacco extracts and tobacco smoke extracts may be useful tools for the study of the effects of central effects of smoking.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17515803     DOI: 10.1097/WNR.0b013e32811d6d21

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  12 in total

1.  Delivery of nicotine in an extract of a smokeless tobacco product reduces its reinforcement-attenuating and discriminative stimulus effects in rats.

Authors:  Andrew C Harris; Irina Stepanov; Paul R Pentel; Mark G Lesage
Journal:  Psychopharmacology (Berl)       Date:  2011-09-30       Impact factor: 4.530

2.  Status and Future Directions of Preclinical Behavioral Pharmacology in Tobacco Regulatory Science.

Authors:  Mark G LeSage; John R Smethells; Andrew C Harris
Journal:  Behav Anal (Wash D C)       Date:  2018-07-09

3.  Animal models to assess the abuse liability of tobacco products: effects of smokeless tobacco extracts on intracranial self-stimulation.

Authors:  Andrew C Harris; Laura Tally; Clare E Schmidt; Peter Muelken; Irina Stepanov; Subhrakanti Saha; Rachel Isaksson Vogel; Mark G LeSage
Journal:  Drug Alcohol Depend       Date:  2014-12-23       Impact factor: 4.492

4.  Association between smoking, nicotine dependence, and BDNF Val66Met polymorphism with BDNF concentrations in serum.

Authors:  Mumtaz Jamal; Willem Van der Does; Bernet M Elzinga; Marc L Molendijk; Brenda W J H Penninx
Journal:  Nicotine Tob Res       Date:  2014-09-02       Impact factor: 4.244

5.  Smoke extracts and nicotine, but not tobacco extracts, potentiate firing and burst activity of ventral tegmental area dopaminergic neurons in mice.

Authors:  Fabio Marti; Ouafa Arib; Carole Morel; Virginie Dufresne; Uwe Maskos; Pierre-Jean Corringer; Renaud de Beaurepaire; Philippe Faure
Journal:  Neuropsychopharmacology       Date:  2011-06-29       Impact factor: 7.853

6.  Abuse liability assessment of an e-cigarette refill liquid using intracranial self-stimulation and self-administration models in rats.

Authors:  M G LeSage; M Staley; P Muelken; J R Smethells; I Stepanov; R I Vogel; P R Pentel; A C Harris
Journal:  Drug Alcohol Depend       Date:  2016-09-01       Impact factor: 4.492

7.  The development of nicotinic receptors in the human medulla oblongata: inter-relationship with the serotonergic system.

Authors:  Jhodie R Duncan; David S Paterson; Hannah C Kinney
Journal:  Auton Neurosci       Date:  2008-11-05       Impact factor: 3.145

Review 8.  Systems-level perspective of sudden infant death syndrome.

Authors:  Nathan Salomonis
Journal:  Pediatr Res       Date:  2014-06-25       Impact factor: 3.756

9.  Comparison of the reinforcing properties of nicotine and cigarette smoke extract in rats.

Authors:  Matthew R Costello; Daisy D Reynaga; Celina Y Mojica; Nurulain T Zaveri; James D Belluzzi; Frances M Leslie
Journal:  Neuropsychopharmacology       Date:  2014-02-11       Impact factor: 7.853

10.  Nicotine-, tobacco particulate matter- and methamphetamine-produced locomotor sensitisation in rats.

Authors:  Katharine A Brennan; Fraser Putt; Penelope Truman
Journal:  Psychopharmacology (Berl)       Date:  2013-03-22       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.